Hernan Trimarchi HOSPITAL BRITANICO DE BUENOS AIRESArgentina

Professor Hernán Trimarchi graduated from the University of Buenos Aires Medical School in Argentina in 1990. He completed a post-doctoral renal research fellowship at Baylor School of Medicine, Houston, Texas, US in 1997-1998. He has been appointed as Head of the Division of Nephrology and Renal Transplantation at the Hospital Británico de Buenos Aires since 2006. He was awarded a PhD in 2010. He is Professor of Medicine at the Universidad Católica Argentina. He is a member of the Steering Committee of the International IgA Nephropathy Network, member of the ISN Continuing Medical Education Program Committee since 2020, ISN member of the ISN Latin America Regional Board since 2021, and Editor-in-Chief of the Journal of the Argentinian Society of Nephrology. He is a Fellow of the American Society of Nephrology and of the American College of Physicians; active member of the International Society of Nephrology and of the International Society of Transplantation. He is member of the editorial board of many nephrology journals and has written and edited many nephrology book chapters, nearly 180 original papers, of which over 100 are indexed in PubMed. Finally, he leads clinical trials mainly related to glomerulopathies.

1 APRIL 2023

Time Session
17:00
18:00
  • Acid-base and Electrolyte Abnormalities in Kidney Disease
    Andréa Stinghen Moderator Universidade Federal do ParanáBrazil
  • Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
    Rolando Claure-Del Granado Moderator Hospital Obrero No 2 - C.N.S.Bolivia
  • Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
    Kraiwiporn KIATTISUNTHORN Moderator Siriraj HospitalThailand
  • Chronic Kidney Disease Diagnosis, Classification and Progression 2
    Richard Kitching Moderator Monash University, Monash Medical CenterAustralia
  • Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
    Wenjun Ju Moderator wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
  • Clinical Glomerulonephritis 3
    Hernan Trimarchi Moderator HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Covid-19 and CKD
    Opeyemi Olabisi Moderator Duke UniversityUnited States
  • Curriculum
    Prapaipim Thirakhupt Moderator prapaipimt@yahoo.com
  • Diabetic Kidney Disease, Drugs and Treatments 2
    Dr Giorgina Barbara Piccoli Moderator gpiccoli@ch-lemans.frCHM Le MansFrance
  • Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
    Sabine Karam Moderator Saint George Hospital University Medical CenterLebanon
  • Epidemiology, Outcomes and Health Services Research in Dialysis 2
    Ana Elizabeth Figueiredo Moderator anaef@pucrs.brBrazil
  • Essential Hypertension and Renovascular Kidney Disease
    Barry Freedman Moderator Wake Forest University School of Medicine United States
  • Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
    Chairat Shayakul Moderator Faculty of Medicine Siriraj Hospital, THAILANDThailand
  • Haemodialysis, Haemodiafiltration and Vascular Access 2
    Brendan Smyth Moderator St George HospitalAustralia
  • Haemodialysis, Haemodiafiltration and Vascular Access 3
    Jonathan Himmelfarb Moderator jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
  • Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
    Youhua LIU Moderator University of PittsburghUnited States
  • Kidney Transplantation and Transplant Immunology 3
    Narayan Prasad Moderator Sanjay Gandhi Post Graduate Institute of Medical SIndia
  • Kidney Transplantation and Transplant Immunology 4
    Professor Yingyos Avihingsanon Moderator yingyos@hotmail.com
  • Late Breaking Clinical Trials
    Muh Geot Wong Moderator University of SydneyAustralia
  • Nephrotic Syndrome
    Alessia Fornoni Moderator University of MiamiUnited States
  • Other CKD 2
    Jie Dong Moderator jie.dong@bjmu.edu.cnPeking University First HospitalChina
  • Other KF (Kidney Failure)
    Tai Shuan Lai Moderator National Taiwan University HospitalTaiwan
  • Peritoneal Dialysis 2
    Piyatida Chuengsaman Moderator Thailand
  • Peritoneal Dialysis 3
    Afiatin Abdurahman Moderator
  • Training
    Naowanit Nata Moderator
  • Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
    Opas Traitanon Moderator
  • Urologic Disorders – Stones, Nephrocalcinosis
    Sritippayawan Suchai Moderator Siriraj Hospital Thailand
  • Vascular Biology and Endothelial Function
    Reiko Inagi Moderator Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall

30 MARCH 2023

Time Session
11:00
13:00
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Establishing and Conducting Your Trial
    Hong Zhang Speaker Peking University First HospitalChina
  • Q and A
  • Global Representation in Large Trials
    Hernan Trimarchi Speaker HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Q and A
  • Innovations in Trial Conduct
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
MR 110

INDUSTRY SYMPOSIA PROGRAM (FRIDAY, MARCH 31, 2023)

Time Session
13:00
14:00
Organized by Chinook Therapeutics
Adrian Liew Chairperson draliew2@gmail.comMount Elizabeth Novena HospitalSingapore
  • Atrasentan for the Treatment of IgA Nephropathy: Interim Results from the AFFINITY Study
    Adrian Liew Speaker draliew2@gmail.comMount Elizabeth Novena HospitalSingapore
  • Updated Interim Results of a Phase 1 / 2 Study of BION-1301 in Patients with IgA Nephropathy
    Hernan Trimarchi Speaker HOSPITAL BRITANICO DE BUENOS AIRESArgentina
MR 110